These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 28748958)

  • 1. New and revisited approaches to preserving the reperfused myocardium.
    Kloner RA; Brown DA; Csete M; Dai W; Downey JM; Gottlieb RA; Hale SL; Shi J
    Nat Rev Cardiol; 2017 Nov; 14(11):679-693. PubMed ID: 28748958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?
    Bulluck H; Foin N; Tan JW; Low AF; Sezer M; Hausenloy DJ
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28242607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
    Allencherril J; Alam M; Levine G; Jneid H; Atar D; Kloner RA; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):215-224. PubMed ID: 30563349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No-reflow phenomenon: maintaining vascular integrity.
    Kloner RA
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the no-reflow phenomenon.
    Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
    Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of left ventricular deformation in the assessment of microvascular obstruction and intramyocardial haemorrhage.
    Garg P; Kidambi A; Swoboda PP; Foley JR; Musa TA; Ripley DP; Erhayiem B; Dobson LE; McDiarmid AK; Fent GJ; Haaf P; Greenwood JP; Plein S
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):361-370. PubMed ID: 27785677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between R-wave peak time and no-reflow in ST elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Çağdaş M; Karakoyun S; Rencüzoğullari İ; Karabağ Y; Yesin M; Uluganyan M; Gürsoy MO; Artaç İ; İliş D; Efe SÇ; Taşar O
    Coron Artery Dis; 2017 Jun; 28(4):326-331. PubMed ID: 28207567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvalvular Ventricular Unloading Before Reperfusion in Acute Myocardial Infarction.
    Swain L; Reyelt L; Bhave S; Qiao X; Thomas CJ; Zweck E; Crowley P; Boggins C; Esposito M; Chin M; Karas RH; O'Neill W; Kapur NK
    J Am Coll Cardiol; 2020 Aug; 76(6):684-699. PubMed ID: 32762903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of no reflow and microvascular obstruction in the prognostic stratification of STEMI patients.
    Durante A
    Anatol J Cardiol; 2018 May; 19(5):346-349. PubMed ID: 29537970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of No-Reflow Phenomenon in the Catheterization Laboratory.
    Rezkalla SH; Stankowski RV; Hanna J; Kloner RA
    JACC Cardiovasc Interv; 2017 Feb; 10(3):215-223. PubMed ID: 28183461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INNOVATION Study (Impact of Immediate Stent Implantation Versus Deferred Stent Implantation on Infarct Size and Microvascular Perfusion in Patients With ST-Segment-Elevation Myocardial Infarction).
    Kim JS; Lee HJ; Woong Yu C; Kim YM; Hong SJ; Park JH; Choi RK; Choi YJ; Park JS; Kim TH; Jang HJ; Joo HJ; Cho SA; Ro YM; Lim DS
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
    Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
    Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
    Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
    Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse diastolic remodeling after reperfused ST-elevation myocardial infarction: An important prognostic indicator.
    Nguyen TL; Phan J; Hogan J; Hee L; Moses D; Otton J; Premawardhana U; Rajaratnam R; Juergens CP; Dimitri H; French JK; Richards D; Thomas L
    Am Heart J; 2016 Oct; 180():117-27. PubMed ID: 27659890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
    de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.